Click on a filter below to refine your search. Remove a filter to broaden your search.
Patients who received 2 or 3 mg of Rexulti had significant improvements in agitation scores compared with patients taking a placebo.
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
The all-cause dementia risk was greater for those with treated and untreated hypertension compared with healthy controls.
Associations were seen for chronic and new-onset anxiety, but not for resolved anxiety, with all-cause dementia risk.
Significant associations were seen for all Alzheimer’s disease plasma biomarkers in late life with late-life dementia.
More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at
Tau positron emission tomography predicts all-cause dementia and Alzheimer disease dementia
An even higher risk for young-onset dementia was seen for preeclampsia before 34 weeks of gestation or superimposed on chronic hypertension.
Older age, female sex and progression to symptomatic Alzheimer’s disease were associated with driving cessation.
Readmission rates were highest for those with frailty and probable dementia.